Ziprasidone Impurity P

Development and Validation of an HPLC Method for Determination of Ziprasidone and Its Impurities in Pharmaceutical Dosage Forms
Marija Pavlovic, Marija Malesevic, Katarina Nikolic, Danica Agbaba
Journal of AOAC INTERNATIONAL, Volume 94, Issue 3, 1 May 2011, Pages 713–722
 
Optimization of the Thin-Layer Chromatography Method for the Separation of Ziprasidone and Its Impurities
Darija Obradović, Slavica Filipic, Katarina Nikolic & Danica Agbaba
JPC – Journal of Planar Chromatography – Modern TLC volume 29, pages239–246(2016)
 
Optimization of TLC method for separation and determination of ziprasidone and its impurities
 Darija Obradović,Slavica Filipić,Katarina Nikolić,Marija Čarapić &Danica Agbaba
Journal of Liquid Chromatography & Related Technologies Volume 39, 2016 - Issue 5-6: Special Issue: Thin Layer Chromatography Pages 271-276

Ziprasidone Impurity P is chemically 1,4-Bis(benzo[d]isothiazol-3-yl)piperazine. Ziprasidone Impurity P is supplied with detailed characterization data compliant with regulatory guideline. Ziprasidone Impurity P can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Ziprasidone-.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.